| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |